Severity
Moderate
FDA Drug recall · Reported February 5, 2014
Lack of Assurance of Sterility; potential leakage from administrative port.
Hospira Inc. recalled Aminosyn 3.5% M Sulfite-Free, A Crystalline Amino Acid Solution* with Maintenance Electro… - a moderate-severity action.
Aminosyn 3.5% M Sulfite-Free, A Crystalline Amino Acid Solution* with Maintenance Electro… was recalled by Hospira Inc. in February 5, 2014. Reason: Lack of Assurance of Sterility; potential leakage from administrative port.. Check the official notice for the remedy. Verify recall #D-1035-2014 with the FDA Drug before acting.
The recall
Hospira Inc. issued this moderate-severity FDA Drug recall-Lack of Assurance of Sterility; potential leakage from administrative port..
Sourced from official FDA Drug enforcement records. Verify recall #D-1035-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1035-2014) was formally reported on February 5, 2014, with the manufacturer initiating the action on January 9, 2014. It is classified under Moderate severity (Class II), with a current status of Terminated. Hospira Inc. is listed as the recalling firm, operating out of Lake Forest, IL. Federal records list the affected scope as 15258 bags.
The documented reason for this recall is: Lack of Assurance of Sterility; potential leakage from administrative port. Distribution data in the federal record shows the product reached: Nationwide including Puerto Rico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 2,002 dietary supplements recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
15258 bags
Related Recalls
6
0 from same agency
Aminosyn 3.5% M Sulfite-Free, A Crystalline Amino Acid Solution* with Maintenance Electrolytes with Phosphorus, 1000 mL bag, Rx only. Hospira Inc, Lake Forest, IL, 60045. NDC: 0409-4196-05
Lack of Assurance of Sterility; potential leakage from administrative port.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1035-2014 |
| Date reported | February 5, 2014 |
| Date initiated | January 9, 2014 |
| Recalling firm | Hospira Inc. |
| Firm location | Lake Forest, IL |
| Affected scope | 15258 bags |
| Distribution | Nationwide including Puerto Rico |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Pure Vitamins and Natural Supplements, LLC · 2026-04-15
Pure Vitamins and Natural Supplements, LLC · 2026-04-15
Herbal Creations USA · 2026-04-01
Winder Laboratories, LLC · 2026-03-25
Imu-Tek Animal Health, Incorporated · 2026-02-11
Compare this recall with Blue Bull Extreme Male Enhancement Supplement, total of 15 … →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 5, 2014. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.